CLL
News
‘Agony of choice’ for clinicians treating leukemia
Novel targeted therapies emerge as frontline options while chemoimmunotherapy “fades into the background.”
Conference Coverage
Zanubrutinib shows worth against standard CLL drugs
New CLL drug demonostrates its efficacy in the crowded field of CLL treatment options.
News
When CPI fails, HL patients should get timely allo-HCT
New data suggest that physicians should refer Hodgkin lymphoma patients for allogeneic HCT without delay when PD-1 treatments fail.
News
Survivor’s story foreshadows one of oncology’s greatest successes
In 1992, a young New Yorker was among the first Hodgkin lymphoma patients to undergo a successful bone marrow transplant. Three decades later,...
News
Some leukemias detectable up to 16 years before diagnosis?
Sequencing analysis showed that even high-risk CLL subtypes precursor states may exist up to 16 years longer than previously thought.
Opinion
A little-known offshoot of hem/onc opens pathway for professional development
Among hematologist oncologists, discussion and research is underway on how we evaluate and treat vascular anomalies--a fertile area for...
News
Eating olive oil may slow CLL disease progression
A pilot study in Greece suggested that consuming extra virgin olive oil daily induced the apoptosis of cancer cells.
News
Repurposed drug could revolutionize stem cell transplantation
Abatacept to prevent for acute graft-versus-host disease is a game changer for patients receiving hematopoietic stem cell transplants who lack...
News
Hodgkin-directed therapy may benefit patients with rare CLL subtype
Patients diagnosed with an uncommon subtype of chronic lymphocytic lymphoma show improved outcomes from Hodgkin-directed treatments.
News
9/11 first responders show mutations linked to blood cancers
Blood samples from firefighters and emergency workers at Ground Zero show higher burden of clonal hematopoiesis, suggesting need for mutational...